HORSHAM, Pa., July 27, 2017 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatological conditions, will release second quarter financial results on Thursday, August 10, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Frank J. McCaney, and Christina Allgeier, Chief Financial Officer, will host a conference call at 4:30 pm Eastern Time to review the Company’s progress and answer questions.
| Conference Call Details: | |
| Date: | Thursday, August 10 |
| Time: | 4:30 pm Eastern Time |
| Toll Free: | 888-299-7209 |
| International: | 719-325-4821 |
| Passcode: | 9972674 |
| Webcast: | www.strataskinsciences.com |
| Replays, available through August 24, 2017 | |
| Toll Free: | 844-512-2921 |
| International: | 412-317-6671 |
| Replay PIN: | 9972674 |
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN™ MicroSystem, marketed specifically for the intended use of micropigmentation; and Nordlys, a multi-technology aesthetic laser device.